| Literature DB >> 31190764 |
Daniel Schoene1,2, Claudia Heller1, Yan N Aung1, Cornel C Sieber1,3, Wolfgang Kemmler2, Ellen Freiberger1.
Abstract
Maintaining or improving quality of life (QoL) is a key outcome of clinical interventions in older people. Fear of falling (FoF) is associated with activity restriction as well as with poorer physical and cognitive functions and may be an important contributor to a diminished QoL. The objectives of this systematic review were to determine i) the effect of FoF on QoL in older people, ii) whether the association between these two constructs depends on the use of specific conceptualizations and measurement instruments, and iii) the role of fall events as mediating factor in this relationship. Four electronic databases (PubMed, EMBASE, CINAHL, and Cochrane Library) were searched from their inceptions to February 2018. Thirty mostly cross-sectional studies in nearly 30.000 people (weighted mean age 75.6 years (SD =6.1); 73% women) were included. FoF was associated with QoL in most studies, and this association appeared to be independent of the conceptualization of FoF. Moreover, this relationship was independent of falls people experienced which seemed to have a lower impact. FoF should be considered not only as by-product of falls and targeted interventions in parts different from those to reduce falls are likely required. Studies are needed showing that reducing FoF will lead to increased QoL.Entities:
Keywords: accidental falls; aged; falls efficacy; fear of falling; function; quality of life
Mesh:
Year: 2019 PMID: 31190764 PMCID: PMC6514257 DOI: 10.2147/CIA.S197857
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1Flowchart of study selection process.
Abbreviations: FoF, fear of falling; QoL, quality of life.
Sample sizes, age ranges, mean age (standard deviations), population characteristics, measurements, and main results of fear of falling and quality of life of the included studies
| Reference | Population | Health and falls | FoF measure | FoF estimate/ prevalence | QoL measure | Univariate/unadjusted analyses | Multivariate/adjusted analyses |
|---|---|---|---|---|---|---|---|
| N=261; | Healthy; | mFES (cut point 8) | 23.4% | SF-36 | FoF sig. correlated with all domains of QoL (r 0.199 to 0.430) except role limitation emotional; | 3 domains of SF-36 (PF β=0.150, general health β=0.055, MH β=0.041, all | |
| N=890; | Relatively healthy; | Single question (3 response options) | 29% moderately fearful; 9% very fearful | SRH (2 response options) | Life less than very satisfied in 21/ 633 participants in no FoF, 34/190 in moderate FoF, 25/67 in very FoF ( | FoF associated with fair or poor self-rated health OR =2.89 [1.32, 6.34]; | |
| N=191; | Relatively healthy; | Single question (4 response options); FES-I (no cut point applied) | 21.5% somewhat fearful, 22% fairly fearful, 18.8% very fearful | SF-36 | FoF sig. correlated with all domains of QoL (rs −0.22 to −0.58) | ||
| N=32; | Healthy; | Question/s on concerns about falling (not specified) | 43.8% concerned about falling | WHOQOL-BREF | Mean QoL: | ||
| N=89; | Healthy; without cognitive impairments; 8% walking stick; | Single question (4 response options); FES-I (no cut point reported) | 32.6% somewhat fearful, 19.1% quite a bit fearful, 3.4% very fearful | SF-36 | FoF sig. correlated with all domains of QoL (r −0.310 to −0.655) | ||
| N=1361; | Relatively healthy; mobile; | Single question (not specified) | 60% of fallers are afraid of future falls | SF-36 | Mean QoL: | ||
| N=4056; | Relatively healthy; 13.8% faller | Single question (2 response options) | 53.4%; | SF-36 | Sig. mean differences between FoF and no FoF in all domains | FoF associated with PCS (β=−2.04, SE=0.24) and MCS (β=−2.46, SE=0.24), | |
| N=3824; | No dementia or severe cognitive impairment; 13.6% faller | Single question (2 response options) | 53.4% afraid of falling | SF-36; SRH (5 response options) | Sig. mean differences between FoF and no FoF in all domains for men and women (SF-36 & SRH) | Only included SRH; SRH associated with FoF: reference excellent/very good | |
| N=151; | No major cognitive impairment; 37% walking aid; 48.3% faller | FES (cut point 70); activity restriction (not specified) | 63.6%; 46.9% limited activities because of FoF | Nottingham Health Profile | FoF sig. correlated with QoL(rs=0.64) | ||
| N=135; | Healthy; no major cognitive impairments; no neurodegenerative disease, stroke or depression; mean PPA 0.12 (1.28) | ABC Scale (no cut point applied) | ABC mean score - 87.9 (12.9) at baseline | EQ-5D | FoF sig. correlated with QoL (r=0.48) | FoF independent predictor QoL (ß=0.0019, | |
| N=153; | Healthy; no major cognitive impairment; no mobility limitation or balance problem due to medical conditions; 51% faller | FES-I (low 16–19, moderate 20–27, high 28+) | low FoF 8.5%, moderate FoF 27.5%, high FoF 64% | SRH (5 response options) | FoF sig. correlated with QoL (rs= −0.77) | ||
| N=150; | No major cognitive impairments; 65% walking aid; | Single question (4 response options) | 26% (♂:22%, ♀:27%) | SRH (4 response options) | QoL excellent/good less likely to have FoF OR 0.19 (0.10–0.35), | QoL associated with FoF (ß=0.818, | |
| N=193/182; | Without or with minor mobility restrictions; without severe cognitive or physical impairments; | FES-I | Not reported | SF-12 | FoF sig. correlated with QoL (Germany r= - 0.63, Taiwan r= −0.59) | partial mediation of physical activity and self-concept of health and physical independence in association between FoF and QoL | |
| N=4196/3314/ | With increased risk for hip fractures; | Single question (6 response options) | 5.8% afraid of falls all the time, 5.8% most of the time, 40.1% none of the time | EQ-5D | all levels of FoF sig. associated with QoL; | ||
| N=342; | MMSE>15; increased fall and fracture risk; | FES (no cut point applied) | Mean 45 (22.3) | SF-8 | FoF sig. correlated with all domains of QoL (rs −0.21 to −0.53) except for MCS | FoF associated with all domains of QoL (ß −0.27 to −0.42) except for MCS (β = −0.12, | |
| N=199; | 67% walking aids; 38% receive home services; | General questions (not specified); | 60% very, somewhat or slightly in following year | SHARP | FoF sig. less satisfied with life during past month (FoF 0.87 (0.34) vs no FoF 0.96 (0.19), | ||
| N=270; | Increased fall risk: multimorbidity, recurrent falls within the last 12 months; 37% walking aids; | FES; SAFE | Not reported | SF-36; SRH (rate from 0–10) | More FoF (FES) is associated with lower QoL in all SF-36 domains; | All FoF measures sig. associated with all domains of SF-36 | |
| N=256; | Ability to ambulate with minimal use of assistive device; without cognitive impairments or degenerative diseases; 20% walking aids | Single question (2 response options); SAFFE (latent class analyses) | 38% very afraid; 18.4% high fear based on latent class analyses | SF-12 | PCS: low vs high FoF 51.90±19.43 vs 42.68±17.58, F(1,254)=8.94; | ||
| N=597; | Increased fall risk: recurrent falls or gait impairment and PPA>0; | FES-I (scoring unclear) | Mean 2.7 (1.4) | EQ-5D | FoF associated with QoL (β= −0.122** (95%CI −0.017;−0.005)) | ||
| N=597; | Robust (Rockwood scale); able to walk independently with or without assistance; no major cognitive impairment; 30.3% faller | Chinese FES-I (cut point 23) | 65% | Chinese Personal Wellbeing Index | Mean QoL: | low QoL associated with FoF (OR 0.97 (0.962–0.997), | |
| N=742; | No major cognitive or sensory impairment; 9% walking aid; 19% dependent in at least 1 ADL; 28.4% faller | FES-BR (cut point 23) | 51.9% | SRH (3 response options) | % FoF according to SRH: very good/good 40.5%, fair 62.6% OR 2.45 (1.80–3.35), poor/very poor 88.4% OR 11.16 (3.82–32.57), | Lower QoL sig. associated with FoF: fair 2.36 (1.71–3.25), poor/very poor OR 11.22 (3.71–33.93) | |
| N=409; | increased fall risk: fall within the last 12 months; no major cognitive impairment (MMSE>20); no degenerative diseases; no ADL impairment; | FES-I (low 16–19, moderate 20–27, high 28+) | 21.9% high concern, 45.8% moderate concern, 32.3% low concern | LEIPAD; | Poor but not moderate QoL associated with FoF: | ||
| N=243; | Frail (dependence in ADL or prolonged bed rest or impaired | MFES (no cut point applied) | Median 103.0 (95%CI 99–107) | SF-36 | FoF sig. correlated with QoL (r 0.61 to −0.80) | FoF associated with physical components of QoL (PCS β=0.13; SE=0.03, | |
| N=289; | No cognitive impairment; mobile over 10 m with or without a walking aid; no stroke or major surgery in past 6 months; 45.3% walking aid; 46% faller | ABC scale (tertiles: low 0–45%, moderate 45–71%, high 71–100%) | One third low confidence | EQ-5DVAS | Mean QoL: | ||
| N=135; | Frail, functional impairments; sufficient cognition to answer questionnaire; | Single question (3 response options) | 16.3% very fearful; | SF-36 | ♂ no FoF: RP (role limitations) and SF (social functioning) higher scores than moderate FoF ( | ||
| N=449; | No major cognitive impairments; 26.5% walking aids; | Adapted FES | Mean 94.9 (12.0) | SRH (5 response options); SPF-IL (Well-Being) | FoF sig. correlated with QoL (SRH r=0.512, | FoF sig. associated with QoL (SRH OR=1.133, | |
| N=153; | No recent deterioration in mobility; able to recall at least 3 of 5 items in a test of recent memory; 56% walking aids; | CAFlik | Not reported | PGMS | FoF sig. correlated with QoL (r=−0.40) | Structural equation modelling found no direct or indirect effect of falls, balance confidence and falls efficacy on QoL | |
| N=68; | Not bedridden; 79% walking aids; | FoF subscale (7 items; min 7, max 21, higher scores indicate lower FoF) | Mean 14.8 (5.1) | NHP | FoF sig. correlated with all domains of QoL (r 0.32 to 0.64) | ||
| N=100; | Functionally independent; | SAFFE | Not reported | SRH (5 response options) | FoF sig. correlated with QoL (r=−0.28) | QoL not associated with FoF (β=−0.06, | |
| N=394; | 58% at least 1 chronic condition; 87% walking impairment; 34% fall in aging life | Single question (3 response options) | 74.1% low fear, 23.6% moderate fear, 2.3% high fear | Mod WHOQOL-OLD (low 24–55, moderate 56–88, high 89–120) | No FoF not associated with QoL (OR 1.264 (0.695–2.299)); |
Abbreviations: FES, Falls Efficacy Scale; FES-I - Falls Efficacy Scale International; MFES, Modified Falls Efficacy Scale; ABC Scale, Activities Balance Confidence Scale; SAFE/SAFFE, Survey of Activities and Fear of Falling in the Elderly; CAFlik, Concern and Fear about Falling; SF-36, Medical Outcome Study 36-Item Short-Form Health Survey (subscales: PF, Physical Function; RP - Role Limitation Physical; BP, Bodily Pain; GH, General Health; V, Vitality; SF, Social Function; RE, Role Limitation Emotional; MH, Mental Health; PCS, Physical Component Scale; MCS, Mental Component Scale); SF-12, MOS 12-Item Short-Form Health Survey; SF-8, MOS 8-Item Short-Form Health Survey; EQ-5D, EuroQol-5D; WHOQOL-BREF, World Health Organization Quality of Life - Short Form WHOQOL-100; WHOQOL-OLD, World Health Organization Quality of Life – Older Adults Module; SHARP, Short Happiness and Affect Research Protocol, WHO-5–5-item World Health Organization Well-Being Index; SPF-IL, Social Production Function Instrument for the Level of Well-Being; PGMS, Philadelphia Geriatric Morale Scale; NHP, Nottingham Health Profile; NPH, Nottingham Health Profile (Subscales: energy, sleep, physical mobility, pain, emotional reaction, social isolation; SRH, self-rated health; SWB, subjective well-being; PPA, Physiological Profile Assessment; VAS, visual analogue scale; CD, community-dwelling; R, Pearson product-moment correlation coefficient, Rs, Spearman’s rank correlation coefficient; OR, odds ratio.
Rating of methodological quality of included studies using the ‘Quality assessment tool for observational cohort and cross-sectional studies’29
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akosile et al 2014 | Yes | NR | Yes | No | No | No | Yes | NA | Yes | NR | NA | No | ||
| Arfken et al 1994 | Yes | Yes | Yes | No | No | No | Yes | NA | Yes | NR | NA | Yes | ||
| Baharlouei et al 2013 | Yes | NR | Yes | No | No | No | Yes | NA | Yes | NR | NA | No | ||
| Basalan and Atay 2014 | Yes | No | Yes | No | No | No | CD | NA | Yes | NR | NA | No | ||
| Billis et al 2011 | Yes | NR | Yes | No | No | No | Yes | NA | Yes | NR | NA | No | ||
| Chang, Yang and Chou 2010 | Yes | Yes | Yes | No | No | No | CD | NA | Yes | NR | NA | No | ||
| Chang et al 2010 | Yes | Yes | Yes | No | No | No | Yes | NA | Yes | NR | NA | Yes | ||
| Chang et al 2016 | Yes | Yes | Yes | No | No | NA | Yes | NA | Yes | NR | NA | Yes | ||
| Cinarli et al 2017 | Yes | Yes | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | No | ||
| Davis et al 2011 | Yes | Yes | Yes | No | CD | Yes | Yes | No | Yes | NR | Yes | No | ||
| Hoang et al 2017 | Yes | NR | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | No | ||
| Howland et al 1993 | Yes | Yes | Yes | No | No | No | Yes | NA | Yes | NR | NA | Yes | ||
| Hsu et al 2013 | Yes | NR | No | No | No | Yes | Yes | NA | Yes | NR | NA | No | ||
| Iglesias et al 2009 | Yes | No | No | No | No | Yes | Yes | NA | Yes | NR | NA | Yes | ||
| Kato et al 2008 | Yes | Yes | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | Yes | ||
| Kloseck et al 2007 | Yes | No | Yes | No | No | Yes | CD | NA | Yes | NR | NA | Yes | ||
| Lachman et al 1998 | Yes | Yes | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | Yes | ||
| Li et al 2003 | Yes | CD | Yes | No | No | No | Yes | NA | Yes | NR | NA | No | ||
| Lin et al 2015 | Yes | NR | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | No | ||
| Liu et al 2015 | Yes | NR | Yes | No | No | No | Yes | NA | Yes | NR | NA | Yes | ||
| Malini et al 2016 | Yes | NR | Yes | No | No | No | Yes | NA | Yes | NR | NA | Yes | ||
| Patil et al 2014 | Yes | Yes | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | Yes | ||
| Stretton et al 2006 | Yes | No | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | No | ||
| Stubbs et al 2016 | Yes | Yes | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | No | ||
| Suzuki et al 2002 | Yes | NR | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | No | ||
| Tiernan et al 2014 | Yes | Yes | Yes | No | No | Yes | CD | NA | Yes | NR | NA | Yes | ||
| Valentine et al 2011 | Yes | Yes | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | Yes | ||
| Warnke et al 2004 | Yes | Yes | Yes | No | No | Yes | CD | NA | Yes | NR | NA | No | ||
| Yeung et al 2006 | Yes | Yes | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | Yes | ||
| Yodmai et al 2015 | No | NR | Yes | No | No | Yes | Yes | NA | Yes | NR | NA | Yes |
Notes: 1. Was the research question or objective in this paper clearly stated?; 2. Was the study population clearly specified and defined?; 3. Was the participation rate of eligible persons at least 50%?; 4. Were all the subjects selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants?; 5. Was a sample size justification, power description, or variance and effect estimates provided?; 6. For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured?; 7. Was the timeframe sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed?; 8. For exposures that can vary in amount or level, did the study examine different levels of the exposure as related to the outcome (eg, categories of exposure, or exposure measured as continuous variable)?; 9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and implemented consistently across all study participants?; 10. Was the exposure(s) assessed more than once over time?; 11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and implemented consistently across all study participants?; 12. Were the outcome assessors blinded to the exposure status of participants?; 13. Was loss to follow-up after baseline 20% or less?; 14. Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)? As in most studies had objectives differed to the question of this review, we decided Not to apply Items 1 and 5.
Abbreviations: CD, community dwelling; NR, not reported; NA, not applicable.